Galapagos NV stock price

Galapagos NV latest news:


  • 02/19/2018 00:01:47

    BRIEF-Galapagos And MorphoSys Present Results From Phase 1 Study With MOR106 In Atopic Dermatitis

    Galapagos: * GALAPAGOS AND MORPHOSYS ANNOUNCED ON SATURDAY THAT MOR106 WAS GENERALLY WELL TOLERATED IN ATOPIC DERMATITIS PATIENTS. * MOR106 SHOWED FIRST SIGNS OF ACTIVITY AND DURABLE. * RESPONSES.

  • 01/08/2018 00:10:50

    BRIEF-Galapagos Reports Preliminary Topline Results In Osteoarthritis Study

    GALAPAGOS NV: * REPORTED ON SUNDAY, POSITIVE PRELIMINARY TOPLINE RESULTS WITH A PHASE 1B STUDY IN OSTEOARTHRITIS PATIENTS IN THE UNITED STATES. * IN THIS PHASE 1B STUDY IN PATIENTS, GLPG1972 WAS WELL TOLERATED. * THERE WAS ONE TREATMENT DISCONTINUATION WITH REVERSIBLE ABNORMAL LIVER FUNCTION TEST ON DAY 15 IN THE HIGHEST DOSE COHORT. Source text : http://bit.ly/2CCrjZk Further company coverage:

  • 11/23/2017 14:04:21

    BRIEF-Galapagos NV ‍announces share capital increase arising from warrant exercises​

    * ‍Announces a share capital increase arising from warrant exercises​

  • More trends:

    Galectin Therapeutics Inc.GALT | Galectin Therapeutics Inc.GALTU | Galectin Therapeutics Inc.GALTW | Galena Biopharma, Inc.GALE | Galmed Pharmaceuticals Ltd.GLMD | Gaming and Leisure Properties, Inc.GLPI | Gaming Partners International CorporationGPIC | Garmin Ltd.GRMN | Garnero Group Acquisition CompanyGGAC | Garnero Group Acquisition CompanyGGACR |